Interaction analysis between genetic polymorphisms and pharmacodynamic effect in patients treated with adjunctive cilostazol to dual antiplatelet therapy: results of the ACCEL-TRIPLE (Accelerated Platelet Inhibition by Triple Antiplatelet Therapy According to Gene Polymorphism) study

AIMS: Although adjunctive cilostazol to dual antiplatelet therapy can reduce the risks of clinical events after percutaneous coronary intervention (PCI), whether genetic polymorphism can influence the pharmacodynamics of this regimen has not been evaluated. METHODS: One hundred and twenty-seven pati...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kim, In-Suk, Jeong, Young-Hoon, Park, Yongwhi, Yoon, Seong-Eun, Kwon, Tae Jung, Park, Jeong Rang, Hwang, Seok-Jae, Koh, Eun-Ha, Kwak, Choong Hwan, Hwang, Jin-Yong, Kim, Sunjoo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Blackwell Science Inc 2012
Gaiak:
Pharmacogenetics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3376439/
https://ncbi.nlm.nih.gov/pubmed/22007612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2011.04131.x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak